Works matching IS 11707690 AND DT 2022 AND VI 40 AND IP 7

Results: 8

Authors' Reply to Comment on "Risk-Adjusted Performance Measures".

Published in:

PharmacoEconomics, 2022, v. 40, n. 7, p. 741, doi. 10.1007/s40273-022-01154-6

By:

Elbasha, Elamin H.

Publication type:

Article

Risk-Adjusted Performance Measures: A Comment on Elbasha.

Published in:

PharmacoEconomics, 2022, v. 40, n. 7, p. 739, doi. 10.1007/s40273-022-01153-7

By:

Sendi, Pedram;
Schwenkglenks, Matthias

Publication type:

Article

Prices and Clinical Benefit of National Price-Negotiated Anticancer Medicines in China.

Published in:

PharmacoEconomics, 2022, v. 40, n. 7, p. 715, doi. 10.1007/s40273-022-01161-7

By:

Zhang, Yichen;
Wei, Yuxuan;
Li, Huangqianyu;
Chen, Yixuan;
Guo, Yiran;
Han, Sheng;
Shi, Luwen;
Guan, Xiaodong

Publication type:

Article

Clinical Benefit and Cost Effectiveness of Risk-Stratified Gastric Cancer Screening Strategies in China: A Modeling Study.

Published in:

PharmacoEconomics, 2022, v. 40, n. 7, p. 725, doi. 10.1007/s40273-022-01160-8

By:

Qin, Shuxia;
Wang, Xuehong;
Li, Sini;
Tan, Chongqing;
Zeng, Xiaohui;
Luo, Xia;
Yi, Lidan;
Peng, Liubao;
Wu, Meiyu;
Peng, Ye;
Wang, Liting;
Wan, Xiaomin

Publication type:

Article

Considerations Around Coding the Membership Probability Function in a Latent Class Analysis: Renewed Insights.

Published in:

PharmacoEconomics, 2022, v. 40, n. 7, p. 653, doi. 10.1007/s40273-022-01155-5

By:

Boeri, Marco;
Hauber, Brett;
Cappelleri, Joseph C.

Publication type:

Article

Cost-Effectiveness Analysis of Molnupiravir Versus Best Supportive Care for the Treatment of Outpatient COVID-19 in Adults in the US.

Published in:

PharmacoEconomics, 2022, v. 40, n. 7, p. 699, doi. 10.1007/s40273-022-01168-0

By:

Goswami, Hardik;
Alsumali, Adnan;
Jiang, Yiling;
Schindler, Matthias;
Duke, Elizabeth R.;
Cohen, Joshua;
Briggs, Andrew;
Puenpatom, Amy

Publication type:

Article

Addressing Challenges to Alternative Payment Models for New Alzheimer's Disease Therapies for US Commercial Payers.

Published in:

PharmacoEconomics, 2022, v. 40, n. 7, p. 647, doi. 10.1007/s40273-022-01150-w

By:

Hlávka, Jakub P.;
Lavelle, Tara A.;
Neumann, Peter J.;
Lin, Pei-Jung

Publication type:

Article

Preference Elicitation Techniques Used in Valuing Children's Health-Related Quality-of-Life: A Systematic Review.

Published in:

PharmacoEconomics, 2022, v. 40, n. 7, p. 663, doi. 10.1007/s40273-022-01149-3

By:

Bailey, Cate;
Howell, Martin;
Raghunandan, Rakhee;
Salisbury, Amber;
Chen, Gang;
Coast, Joanna;
Craig, Jonathan C.;
Devlin, Nancy J.;
Huynh, Elisabeth;
Lancsar, Emily;
Mulhern, Brendan J.;
Norman, Richard;
Petrou, Stavros;
Ratcliffe, Julie;
Street, Deborah J.;
Howard, Kirsten;
Viney, Rosalie;
the Quality of Life in Kids: Key Evidence to Strengthen Decisions in Australia (QUOKKA), Tools for Outcomes Research to Measure, Value Child Health (TORCH) Project Teams;
Dalziel, Kim;
Hiscock, Harriet

Publication type:

Article